Novo Nordisk A/S technical analysis
Technical analysis of Novo Nordisk A/S (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Novo Nordisk A/S
Novo Nordisk A/S is a Danish pharmaceutical company engaged in the research, development, manufacture, and distribution of pharmaceutical products. The company operates primarily in the obesity and diabetes care segment, as well as in the rare disease segment, offering products for the treatment of diabetes, obesity, cardiovascular conditions, and rare blood disorders. The company also markets smart insulin pens, injection devices, and therapies for weight management, operating in Europe, North America, Asia, Latin America, and other geographic regions.
Description generated automatically from public sources; it may be inaccurate or out of date.
Novo Nordisk A/S: latest session data
Closing values for September 4, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
298.49 DKK
+0.14%
50 sessions
309.31 DKK
−3.37%
200 sessions
291.13 DKK
+2.67%
Session levels
s2
293.85
Support
s1
297.70
Support
pivot
303.80
Pivot
r1
307.65
Resistance
r2
313.75
Resistance
How to read it
In the September 4, 2026 session Novo Nordisk A/S closed lower at 298.90 DKK, −0.88% versus the previous session.
The price sits mixed against its moving averages: +0.14% against the 21-session average, −3.37% against the 50 and +2.67% against the 200.
The 14-period RSI reads 48.0, in neutral territory.
MACD stands at -2.040 against a signal line at -2.663: the histogram is positive (+0.624).
ADX reads 14.9, indicating weak directionality.
Levels computed on the latest session place supports at 297.70 and 293.85 DKK and resistances at 307.65 and 313.75 DKK, around a pivot of 303.80.
The average daily range (ATR) is 9.086 DKK, or 3.04% of price.
Turnover was 3.1M shares, 80% of the 20-session average.
Over the last twelve months the price ranged between 217.96 and 334.44 DKK, and today stands −10.63% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the NOVO-B.CO analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Novo Nordisk A/S
How is Novo Nordisk A/S analysed technically?
Technical analysis of Novo Nordisk A/S is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Novo Nordisk A/S?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Novo Nordisk A/S?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Novo Nordisk A/S it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.